Naloxegol (Movantik®) Provides Rapid Response and Sustained Improvement of Opioid-Induced Constipation Symptoms in Older Adults

Naloxegol (Movantik®), an oral peripherally acting mu-opioid receptor antagonist (PAMORA) has demonstrated rapid and predictable relief of OIC in patients treated with opioids for chronic non-cancer pain in two phase 3 trials (KODIAC 4/5; NCT01309841/NCT01323790). In subjects ≥65 yrs, naloxegol (25m...

Full description

Saved in:
Bibliographic Details
Published inPain management nursing Vol. 24; no. 2; pp. 237 - 238
Main Authors McLeskey, Charles, Brenner, Darren, Rockett, Carol, Jamindar, Mansi, Bortey, Enoch, Hale, Martin, Mallick-Searle, Theresa
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.04.2023
Online AccessGet full text
ISSN1524-9042
1532-8635
DOI10.1016/j.pmn.2023.02.018

Cover